About this episode

CEO Sara Barrington of Verici DX discusses the company's FY'25 results and outlook in an upbeat interview.

In this upbeat interview, CEO Sara Barrington of Verici DX – a next generation medical diagnostics firm focusing on the global kidney transplant market - takes me through last week’s ‘in line’ FY’25 results and positive outlook. Disclosure: Verici is a Vox Markets client

People in this episode

Host: Vox Markets Podcast

Guest: Sara Barrington

Topics covered

• medical diagnostics
• kidney transplant
• financial results
• business outlook
• interview

Keywords

• Verici DX
• Sara Barrington
• kidney transplant
• medical diagnostics
• FY'25 results
• business outlook

Mentioned in this episode

Organizations: Verici DX, Vox Markets

More episodes of The Vox Markets Podcast

• 2448: The Exchange with Richard Crow · July 20, 2026 · 1h 49m
• 2447: 2 P's on a Pod: Could More UK Takeovers Follow? · July 17, 2026 · 1h 19m
• 2446: Winshear Metals: Massive sulphides at Portsoy? · July 16, 2026 · 8 min
• 2445: Poolbeg’s Big Biotech Moment? First Patient Dosed Ahead of Key POLB 001 Data · July 13, 2026 · 8 min
• 2444: European Green Transition: Potential £126m Repowering Revenue Opportunity · July 13, 2026 · 7 min
• 2443: 2 P's on a Pod: What Happens Next for UK Small Caps? · July 10, 2026 · 1h 20m

Explore listener stats, chart rankings, contacts and more on the The Vox Markets Podcast podcast page.